Doxepin Tablet
Product Images NDC 27241-281

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxepin (NDC 27241-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3mg (Doxepin 3mg)

This text provides information about Doxepin tablets, each containing 3.39 mg of doxepin hydrochloride, equivalent to 3 mg of doxepin. The dosage and use instructions can be found in the accompanying Prescribing Information. The tablets should be stored at 20°C to 25°C with excursions permitted to 15°C to 30°C. The package is child-resistant and should be dispensed in a tight, light-resistant container with a child-resistant closure. The product is marketed by Ajanta Pharma USA Inc. in Bridgewater, NJ. This text also includes a code number, NDC number, and advises pharmacists to dispense the accompanying Medication Guide to each patient.*

FDA Label Image

6mg (Doxepin 6mg)

This text provides information regarding doxepin tablets, specifying the amount of doxepin hydrochloride contained in each tablet. It also includes dosage instructions, storage conditions, child-resistant packaging, and details about the manufacturer. The tablets are child-resistant and should be stored at a controlled room temperature. The text mentions Ajanta Pharma USA Inc. as the marketer and indicates that the tablets are made in India. Additionally, there is a reference to a code number and a National Drug Code (NDC) for identification purposes.*

FDA Label Image

Structure (Doxepin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.